Study Sheds New Light into Process of Malarial Drug Resistance

by VR Sreeraman on November 30, 2008 at 10:13 AM
 Study Sheds New Light into Process of Malarial Drug Resistance

Researchers at the University of Notre Dame have gained significant insights into the process whereby the malaria parasite Plasmodium falciparum develops drug resistance.

Michael Ferdig, a biologist at the University of Notre Dame, pint out that the development of Plasmodium falciparum in the blood is driven by a number of different genes expressed at different times and at different levels.


The researcher revealed that combining classical genetics with cutting-edge genomic methods enabled his team to illuminate previously unrecognised transcriptional complexity and variation in Plasmodium falciparum, and possibly master regulators within large copy number variants that contribute to the drug-resistant phenomena in malaria parasites.

He believes that uncovering the genetic "architecture" of numerous drug responses, and identifying key regulators that control such responses, may help map new approaches to conquering drug resistant malarial genes.

His findings have been reported in two research papers separately published in the journals PLoS Biology and PLoS Genetics.

Source: ANI
Font : A-A+



Recommended Readings

Latest Research News

Could Light Therapy Be a Breakthrough for Alzheimer's?
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Does Twice Daily Stimulation Enhance Alzheimer's Mental Functions?
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Study Sheds New Light into Process of Malarial Drug Resistance Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests